Blood tests

Ortho Clinical Diagnostics Announces Launch of the Interleukin-6 (IL-6) Reagent Pack, Latest Addition to Ortho's Critical Care Blood Testing Menu

Retrieved on: 
Thursday, July 22, 2021
Clinical medicine, Medicine, Branches of biology, Blood tests, Acute-phase proteins, Chemical pathology, Ortho Clinical Diagnostics, Immunologic tests, Ortho, C-reactive protein, Troponin, IVD

IL-6 is gaining utility in the evaluation of the most severe forms of respiratory distress, one of the causes of poor outcomes for patients suffering inflammatory diseases.

Key Points: 
  • IL-6 is gaining utility in the evaluation of the most severe forms of respiratory distress, one of the causes of poor outcomes for patients suffering inflammatory diseases.
  • Ortho's comprehensive critical care menu also includes tests for hs Troponin, NT-pro BNP, Ferritin, CRP, D-dimer, Lactate, and PCT.
  • Ortho Clinical Diagnostics (Nasdaq: OCDX) is one of the world's largest pure-play in vitro diagnostics (IVD) companies dedicated to transforming patient care.
  • Ortho helps its customers enhance clinical outcomes, improve efficiency, overcome staffing challenges and reduce costs.

Ortho Clinical Diagnostics Announces Launch of the Interleukin-6 (IL-6) Reagent Pack, Latest Addition to Ortho's Critical Care Blood Testing Menu

Retrieved on: 
Thursday, July 22, 2021
Clinical medicine, Medicine, Branches of biology, Blood tests, Acute-phase proteins, Chemical pathology, Ortho Clinical Diagnostics, Immunologic tests, Ortho, C-reactive protein, Troponin, IVD

IL-6 is gaining utility in the evaluation of the most severe forms of respiratory distress, one of the causes of poor outcomes for patients suffering inflammatory diseases.

Key Points: 
  • IL-6 is gaining utility in the evaluation of the most severe forms of respiratory distress, one of the causes of poor outcomes for patients suffering inflammatory diseases.
  • Ortho's comprehensive critical care menu also includes tests for hs Troponin, NT-pro BNP, Ferritin, CRP, D-dimer, Lactate, and PCT.
  • Ortho Clinical Diagnostics (Nasdaq: OCDX) is one of the world's largest pure-play in vitro diagnostics (IVD) companies dedicated to transforming patient care.
  • Ortho helps its customers enhance clinical outcomes, improve efficiency, overcome staffing challenges and reduce costs.

Europe Anticoagulant Reversal Drug Market Forecast to 2027 - COVID-19 Impact and Regional Analysis - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 20, 2021
Health, Pharmaceutical, Blood tests, Anticoagulant, Atrial fibrillation

The "Europe Anticoagulant Reversal Drug Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; End User" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Anticoagulant Reversal Drug Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; End User" report has been added to ResearchAndMarkets.com's offering.
  • The anticoagulant reversal drug market in Europe is expected to grow from US$ 270.0 million in 2019 to US$ 655.4 million by 2027; it is estimated to grow at a CAGR of 12.4% from 2019 to 2027.
  • Thus, such high prevalence of atrial fibrillation favor the growth of the anticoagulant reversal drug market in Europe.
  • Thus, it is expected to have minimal impact on the anticoagulant reversal drug market in Europe.

Global Chronic Kidney Disease Epidemiology and Patient Flow Report 2021-2035 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 14, 2021
Health, General Health, Medicine, Medical specialties, Kidney diseases, Branches of biology, Medical terminology, Organ failure, Chronic condition, Chronic kidney disease, Disease, Blood tests, Robert Provenzano, Nephrology

The "Global Chronic Kidney Disease Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Chronic Kidney Disease Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Global Chronic Kidney Disease Epidemiology and Patient Flow Analysis - 2021, provides Chronic Kidney Disease epidemiology, demographics, and patient flow.
  • The research provides population data to characterize Chronic Kidney Disease patients, history of the disease at the population level (Chronic Kidney Disease prevalence, Chronic Kidney Disease incidence) and at the clinical level (from diagnosis to treated patients).
  • Chronic Kidney Disease patient flow: Chronic Kidney Disease prevalence, diagnosed, and drug-treated patients
    Demographics: Chronic Kidney Disease patients by age group, gender
    The data from this research will help executives:
    Establish basis for Chronic Kidney Disease market sizing, assessing market potential, and developing drug forecast models
    Identify Chronic Kidney Disease patients segments through age groups, gender, and disease sub-types
    Evaluate Chronic Kidney Disease market opportunities, identify target patient population
    View source version on businesswire.com: https://www.businesswire.com/news/home/20210714005705/en/

United States Blood Gas and Electrolyte Analyzer Market Report 2021: Prospects, Trends Analysis, Market Size and Forecasts up to 2026 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 14, 2021
Medical devices, Health, Branches of philosophy, Academic disciplines, Philosophy, Blood tests, Acid–base physiology, Electrolyte, Physical chemistry, Analysis

The "United States Blood Gas and Electrolyte Analyzer Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United States Blood Gas and Electrolyte Analyzer Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's offering.
  • The country research report on the United States blood gas and electrolyte analyzer market is a customer intelligence and competitive study of the United States market.
  • The companies and dealers/distributors profiled in the report include manufacturers & suppliers of blood gas and electrolyte analyzer market in the United States.
  • 5) What are the modes of entering the United States blood gas and electrolyte analyzer market?

Continuous Glucose Monitors (CGM) Medical Device Pipeline Products Landscape Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 14, 2021
Diabetes, Health, Medical devices, Medicine, Clinical medicine, Medical specialties, Diabetes, Blood tests, Medical monitoring, Blood glucose monitoring, Continuous glucose monitor, Monitoring, Blood sugar level, Glucose, Medical device

The "Continuous Glucose Monitors - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Continuous Glucose Monitors - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.
  • "Continuous Glucose Monitors - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Continuous Glucose Monitors pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
  • Continuous glucose monitoring system is used for the continuous measurement of blood glucose.
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

Blood Glucose Meters Medical Device Pipeline Product Landscape Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 14, 2021
Diabetes, Health, Medical devices, Diabetes, Medicine, Branches of biology, Clinical medicine, Blood tests, Glucose meter, Blood sugar level, Glucose, Blood glucose monitoring, Diabetes management

The "Blood Glucose Meters - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Blood Glucose Meters - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.
  • "Blood Glucose Meters - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Blood Glucose Meters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
  • Blood Glucose Meter is an electronic diabetic management device used for measuring blood glucose levels.
  • the report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
    In-depth analysis of the product's current stage of development, territory and estimated launch date

Flowsion A/S Receives CE Mark Approval for the Glycostat Automated Blood Glucose Control System

Retrieved on: 
Friday, July 9, 2021
Hospitals, Health, Medical devices, Diabetes, Medical specialties, Clinical medicine, Medicine, Intensive care medicine, Nutrition, Blood tests, Diabetes management, Glucose, Blood sugar level, Intensive care unit

Flowsion, the Denmark-based developer of automated continuous blood glucose control systems for intensive care medicine, today announced the CE (Conformit Europenne) Mark for its Glycostat automated glucose control system for intensive care medicine; GlycostatTM is the only blood glucose control system to be launched in the European Union (EU) with an algorithm which enables automated blood glucose control for patients in intensive care.

Key Points: 
  • Flowsion, the Denmark-based developer of automated continuous blood glucose control systems for intensive care medicine, today announced the CE (Conformit Europenne) Mark for its Glycostat automated glucose control system for intensive care medicine; GlycostatTM is the only blood glucose control system to be launched in the European Union (EU) with an algorithm which enables automated blood glucose control for patients in intensive care.
  • With the CE mark we have reached an important milestone in our efforts to help patients and hospitals solving the important problem of glycemic control in the intensive care unit (ICU).
  • For Flowsion this opens a globally relevant market opportunity, said Hans Jorgen Pedersen, CEO of Flowsion.
  • Flowsion has already performed clinical studies with the system so we know already that Glycostat fulfils the demands of the intensive care units.

Global Blood Glucose Test Strips Market Report 2021-2025 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 30, 2021
Diabetes, Health, Medical devices, Diabetes, Branches of biology, Medicine, Articles, Blood tests, Blood sugar level, Human homeostasis, Glucose, Market analysis, Test strip, Etest, Blood glucose monitoring

The "Global Blood Glucose Test Strips Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Blood Glucose Test Strips Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
  • This study identifies the availability of products on online channels as one of the prime reasons driving the blood glucose test strips market growth during the next few years.
  • The report on blood glucose test strips market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
  • Also, the blood glucose test strips market analysis report includes information on upcoming trends and challenges that will influence market growth.

bioMérieux and Specific Diagnostics announce a co-exclusive distribution agreement for the SPECIFIC REVEAL® Rapid AST system in Europe

Retrieved on: 
Tuesday, June 29, 2021
Blood tests, Blood culture, Vitek, AST, Rapid

REVEAL Rapid AST offers customers an easy to use instrument with a targeted menu, small footprint, and modular design well-suited for a large number of hospitals.

Key Points: 
  • REVEAL Rapid AST offers customers an easy to use instrument with a targeted menu, small footprint, and modular design well-suited for a large number of hospitals.
  • REVEAL Rapid AST system is a perfect complement to bioMrieux's unique suite of systems delivering rapid results including the industry's fastest blood culture system, the BACT/ALERT VIRTUO, and rapid identification with either VITEK MS PRIME or BIOFIRE BCID2, and VITEK 2.
  • The co-exclusive distribution agreement signed between both companies will cover Europe, where the REVEAL Rapid AST has been CE-IVD approved.
  • "We are honored to partner with a world leader as bioMrieux to bring the REVEAL Rapid AST system to microbiology labs across Europe," said Paul A. Rhodes, Ph.D., CEO of Specific.